Christopher M Blanchette - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Christopher M Blanchette

Showing results (61-70 of 76) with videos related to

Pageof 8

Sort By:

Annals of the American Thoracic Society|December 5, 2014

Assessing disparities in the receipt of inhaled corticosteroid prescriptions for asthma by Hispanic and non-Hispanic white patientsAkshay A Kharat, Matthew E Borrego, Dennis W Raisch, et al.

Journal of Health Economics and Outcomes Research|September 4, 2023

Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney DiseaseChristopher M Blanchette, Şerban R Iorga, Aylin Altan, et al.

Applied Health Economics and Health Policy|February 28, 2014

Direct medical costs for complications among children and adults with diabetes in the US commercial payer settingJason Yeaw, Shawn Halinan, Dionne Hines, et al.

The Journal of Asthma : Official Journal of the Association for the Care of Asthma|March 22, 2013

Moderate symptom-based exacerbations as predictors of severe claims-based exacerbations in asthmaSandi J Lane, Hans Petersen, James M Seltzer, et al.

Pharmacoepidemiology and Drug Safety|September 30, 2010

The positive predictive value of a hyperkalemia diagnosis in automated health care dataMarsha A Raebel, Michael L Smith, Gwyn Saylor, et al.

International Journal of Chronic Obstructive Pulmonary Disease|August 18, 2010

Cost-effectiveness of combination fluticasone propionate-salmeterol 250/50 microg versus salmeterol in severe COPD patientsAnand A Dalal, Meaghan St Charles, Hans V Petersen, et al.

Human Vaccines & Immunotherapeutics|June 2, 2016

Estimated incidence of pertussis in people aged <50 years in the United StatesChi-Chang Chen, Catherine Balderston McGuiness, Girishanthy Krishnarajah, et al.

Current Medical Research and Opinion|October 9, 2007

Comparison between spinal surgery blood transfusion services costs and associated treatment practices in the United States and BelgiumChristopher M Blanchette, Ashish V Joshi, Marek Szpalski, et al.

Journal of Medical Economics|July 23, 2009

Burden of blood transfusion in knee and hip surgery in the US and BelgiumChristopher M Blanchette, Ashish V Joshi, Marek Szpalski, et al.

Drugs in Context|April 30, 2015

Progression of autosomal dominant kidney disease: measurement of the stage transitions of chronic kidney diseaseChristopher M Blanchette, Caihua Liang, Deborah P Lubeck, et al.

Pageof 8

Search research articles

Showing results (61-70 of 76) with videos related to

Sort By:

Pageof 8

Annals of the American Thoracic Society|December 5, 2014

Assessing disparities in the receipt of inhaled corticosteroid prescriptions for asthma by Hispanic and non-Hispanic white patientsAkshay A Kharat, Matthew E Borrego, Dennis W Raisch, et al.

Journal of Health Economics and Outcomes Research|September 4, 2023

Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney DiseaseChristopher M Blanchette, Şerban R Iorga, Aylin Altan, et al.

Applied Health Economics and Health Policy|February 28, 2014

Direct medical costs for complications among children and adults with diabetes in the US commercial payer settingJason Yeaw, Shawn Halinan, Dionne Hines, et al.

The Journal of Asthma : Official Journal of the Association for the Care of Asthma|March 22, 2013

Moderate symptom-based exacerbations as predictors of severe claims-based exacerbations in asthmaSandi J Lane, Hans Petersen, James M Seltzer, et al.

Pharmacoepidemiology and Drug Safety|September 30, 2010

The positive predictive value of a hyperkalemia diagnosis in automated health care dataMarsha A Raebel, Michael L Smith, Gwyn Saylor, et al.

International Journal of Chronic Obstructive Pulmonary Disease|August 18, 2010

Cost-effectiveness of combination fluticasone propionate-salmeterol 250/50 microg versus salmeterol in severe COPD patientsAnand A Dalal, Meaghan St Charles, Hans V Petersen, et al.

Human Vaccines & Immunotherapeutics|June 2, 2016

Estimated incidence of pertussis in people aged <50 years in the United StatesChi-Chang Chen, Catherine Balderston McGuiness, Girishanthy Krishnarajah, et al.

Current Medical Research and Opinion|October 9, 2007

Comparison between spinal surgery blood transfusion services costs and associated treatment practices in the United States and BelgiumChristopher M Blanchette, Ashish V Joshi, Marek Szpalski, et al.

Journal of Medical Economics|July 23, 2009

Burden of blood transfusion in knee and hip surgery in the US and BelgiumChristopher M Blanchette, Ashish V Joshi, Marek Szpalski, et al.

Drugs in Context|April 30, 2015

Progression of autosomal dominant kidney disease: measurement of the stage transitions of chronic kidney diseaseChristopher M Blanchette, Caihua Liang, Deborah P Lubeck, et al.

Pageof 8